ClearPoint Neuro (CLPT) Notes Payables (2011 - 2024)

ClearPoint Neuro (CLPT) posted Notes Payables of $10.0 million for Q2 2024, little changed sequentially from $10.0 million in Q1 2024.

ClearPoint Neuro (CLPT) Notes Payables (2011 - 2024) Analysis & Trends

ClearPoint Neuro has reported Notes Payables for 9 years, with the latest figure at $10.0 million in Q2 2024.

Quarterly Notes Payables changed N/A year-over-year to $10.0 million in Q2 2024, while the trailing twelve-month figure through Jun 2024 was $10.0 million (changed N/A YoY) and the FY2017 annual result came in at $95786.0, down 26.98% from the prior year.
Notes Payables held at $10.0 million in Q2 2024 per CLPT's latest filing, from $10.0 million in the prior quarter.
Over five years, Notes Payables peaked at $10.0 million in Q2 2024 and troughed at $10.0 million in Q1 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	199.12 Bn	193.52 Bn	7.27 Bn
2	Stryker	128.79 Bn	125.32 Bn	4.50 Bn
3	Medtronic	119.30 Bn	110.08 Bn	6.41 Bn
4	Boston Scientific	73.50 Bn	72.96 Bn	3.85 Bn
5	Edwards Lifesciences	52.11 Bn	47.86 Bn	1.35 Bn
6	Dexcom	34.62 Bn	32.67 Bn	830.00 Mn
7	GE HealthCare Technologies	34.05 Bn	31.94 Bn	2.18 Bn
8	Koninklijke Philips	26.42 Bn	23.10 Bn	4.55 Bn
9	Steris	23.15 Bn	22.67 Bn	684.20 Mn
10	ClearPoint Neuro	468.49 Mn	439.09 Mn	6.71 Mn

Download Data